beta
/2759MO DAREON®-8: A phase I trial of first-line obrixtamig plus chemotherapy and atezolizumab in extensive-stage small cell lung carcinoma (ES-SCLC)
Abstract

Abstract N/A

RelatedView All
CitationsView All
Citing-
Cited By-